Strategies for Improving Linkage-to-Care After Eye Disease Screening
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorUniversity of California, San Francisco
About this trial
The goal of this randomized, parallel-group, controlled trial is to compare methods of improving linkage-to-care for participants in the Village Integrated Eye Worker II (VIEW II) trial who are referred to the eye hospital following eye disease screening. Participants who are referred to the hospital at an eye screening visit will be randomized to three different linkage-to-care interventions: (1) text message reminders, (2) reminders from health workers, or (3) no intervention. The primary outcome of the trial will be whether or not the participant presented to the eye hospital for a referral visit by 21 days following screening.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Residence in an area without reliable mobile connectivity
Trial design
Design model
Parallel
Treatments tested in this trial
Text Message Reminder
Other interventionParticipants referred to the eye hospital after screening will receive a text message reminding them to attend their referral visit.
Health Worker Visit
Other interventionParticipants referred to the eye hospital after screening will receive a home visit from a health worker reminding them to attend their referral visit.
Treatment groups
3,000 Participants
are divided into 3 treatment groupsGroup A: Text Message RemindersExperimental treatment 1 intervention
Group B: Health WorkerExperimental treatment 1 intervention
Group C: No InterventionNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Referral Visit Attendance
The count of participants who attend the referral visit.
Time frame
21 days after screeningSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of California, San Francisco
Lead sponsor
Seva Foundation
Collaborator
National Eye Institute (NEI)
Collaborator
Source ClinicalTrials.gov